Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
Authors
Keywords
Antibodies, Dengue virus, Vaccine development, Vaccines, Dengue fever, Viral vaccines, Enzyme-linked immunoassays, Vaccination and immunization
Journal
PLoS Neglected Tropical Diseases
Volume 15, Issue 3, Pages e0009258
Publisher
Public Library of Science (PLoS)
Online
2021-03-13
DOI
10.1371/journal.pntd.0009258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by NIH Monovalent Dengue Virus Vaccines
- (2019) Jesica A Swanstrom et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents
- (2019) Shibadas Biswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial
- (2019) Vianney Tricou et al. VACCINE
- Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate
- (2018) Jesica A Swanstrom et al. JOURNAL OF INFECTIOUS DISEASES
- Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4
- (2018) Veronique Barban et al. JOURNAL OF VIROLOGY
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
- (2018) Emily N. Gallichotte et al. PLoS Pathogens
- Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model
- (2018) Bruno Guy et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
- (2017) Aravinda M. de Silva et al. Cold Spring Harbor Perspectives in Biology
- Dissecting the human serum antibody response to secondary dengue virus infections
- (2017) Bhumi Patel et al. PLoS Neglected Tropical Diseases
- Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
- (2016) Leah C. Katzelnick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool
- (2016) Ramapraba Appanna et al. EBioMedicine
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
- (2015) Richard Rupp et al. VACCINE
- A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies
- (2015) E. N. Gallichotte et al. mBio
- Immunodominance Changes as a Function of the Infecting Dengue Virus Serotype and Primary versus Secondary Infection
- (2014) D. Weiskopf et al. JOURNAL OF VIROLOGY
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Dengue and dengue vectors in the WHO European region: past, present, and scenarios for the future
- (2014) Francis Schaffner et al. LANCET INFECTIOUS DISEASES
- A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
- (2014) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
- (2014) Ruklanthi de Alwis et al. PLoS Pathogens
- Utility, Limitations, and Future of Non-Human Primates for Dengue Research and Vaccine Development
- (2014) Carlos A. Sariol et al. Frontiers in Immunology
- A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand
- (2013) Kathryn B. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection
- (2013) Wen-Yang Tsai et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
- (2011) Jorge E. Osorio et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Human Antibody Response to Dengue Virus Infection
- (2011) Wahala M. P. B. Wahala et al. Viruses-Basel
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
- (2011) Ruklanthi de Alwis et al. PLoS Neglected Tropical Diseases
- Immunogenicity of sanofi pasteur tetravalent dengue vaccine
- (2009) Bruno Guy JOURNAL OF CLINICAL VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started